glp 1 atherosclerosis GLP-1 receptor agonists and protection: the vascular endothelium takes center stage | American Journal of Physiology-Heart and Circulatory Physiology Frontiers | Role of glucagon-like

Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society for Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement

I have not seen any data to support microdosing, he said

Stay at a healthy weight

This is why advanced cardiometabolic evaluation may include blood pressure patterns, ApoB, LDL particle burden, lipoprotein(a), triglycerides, insulin resistance, inflammatory markers, body composition, and, when appropriate, imaging-based cardiovascular risk assessment

Chen B, Yu X, Horvath-Diano C, Ortuo MJ, Tschp MH, Jastreboff AM, Schneeberger M (2024) GLP-1 programs the neurovascular landscape